Published in Breast Cancer Res Treat on June 01, 2003
Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res (2014) 1.65
Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin (2013) 1.31
Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol (2013) 1.02
Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev (2006) 0.99
Circadian disruption, Per3, and human cytokine secretion. Integr Cancer Ther (2009) 0.90
Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues. Oncoscience (2015) 0.89
Circadian disruption and breast cancer: an epigenetic link? Oncotarget (2015) 0.89
Does current scientific evidence support a link between light at night and breast cancer among female night-shift nurses? Review of evidence and implications for occupational and environmental health nurses. Workplace Health Saf (2012) 0.80
Circadian clocks and breast cancer. Breast Cancer Res (2016) 0.79
A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats. Comp Med (2012) 0.78
The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis. Endocr Rev (2016) 0.75
Color temperature tunable white-light LED cluster with extrahigh color rendering index. ScientificWorldJournal (2014) 0.75
Constant illumination reduces circulating melatonin and impairs immune function in the cricket Teleogryllus commodus. PeerJ (2015) 0.75
Characterization of locomotor activity circadian rhythms in athymic nude mice. J Circadian Rhythms (2013) 0.75
Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep (2006) 2.94
Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol (2007) 2.68
High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab (2003) 2.67
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res (2005) 2.12
Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect (2007) 2.07
Information Rx: Evaluation of a new informatics tool for physicians, patients, and libraries. Inf Serv Use (2006) 2.01
Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med (2010) 1.70
Mindfulness-based stress reduction lowers psychological distress in medical students. Teach Learn Med (2003) 1.69
Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine (2005) 1.57
Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem (2002) 1.51
Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin (2013) 1.31
A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psychooncology (2006) 1.27
Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry (2005) 1.27
Light visor treatment for jet lag after westward travel across six time zones. Aviat Space Environ Med (2002) 1.21
Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res (2011) 1.20
Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol (1985) (2010) 1.20
Dark-phase light contamination disrupts circadian rhythms in plasma measures of endocrine physiology and metabolism in rats. Comp Med (2010) 1.07
Adverse health effects of nighttime lighting: comments on American Medical Association policy statement. Am J Prev Med (2013) 1.06
Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts. Cancer Res (2011) 1.04
Effects of spectral transmittance through standard laboratory cages on circadian metabolism and physiology in nude rats. J Am Assoc Lab Anim Sci (2013) 1.04
Dim light adaptation attenuates acute melatonin suppression in humans. J Biol Rhythms (2006) 1.01
Integrative medicine research at an academic medical center: patient characteristics and health-related quality-of-life outcomes. J Altern Complement Med (2008) 0.97
Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem (2007) 0.97
Ocular input for human melatonin regulation: relevance to breast cancer. Neuro Endocrinol Lett (2002) 0.96
Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr (2005) 0.96
Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia (2011) 0.95
Human phase response curve to a single 6.5 h pulse of short-wavelength light. J Physiol (2012) 0.95
PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem Biophys Res Commun (2006) 0.91
Melanopsin, photosensitive ganglion cells, and seasonal affective disorder. Neurosci Biobehav Rev (2012) 0.91
Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. Mol Endocrinol (2012) 0.90
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander mission. Sleep (2012) 0.90
Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action. J Pineal Res (2013) 0.89
High-intensity red light suppresses melatonin. Chronobiol Int (2006) 0.87
Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett (2002) 0.87
Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr Cancer Ther (2009) 0.85
Light during darkness and cancer: relationships in circadian photoreception and tumor biology. Cancer Causes Control (2006) 0.84
Photoreception for circadian, neuroendocrine, and neurobehavioral regulation. J Physiol Anthropol (2007) 0.83
Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells. J Pineal Res (2014) 0.80
Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. J Nutr (2004) 0.79
Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid. Cancer Lett (2004) 0.79
Physiologic melatonin concentration, omega-3 fatty acids, and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo. Comp Med (2003) 0.79
Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. J Am Assoc Lab Anim Sci (2006) 0.79
Inferior retinal light exposure is more effective than superior retinal exposure in suppressing melatonin in humans. J Biol Rhythms (2003) 0.77
Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats. Nutr Cancer (2006) 0.76
Toward optimizing lighting as a countermeasure to sleep and circadian disruption in space flight. Acta Astronaut (2005) 0.76
A new surgical technique for perfusion of the epididymal fat pad in situ in rats. Contemp Top Lab Anim Sci (2003) 0.75